♟️ Monday 17 August 2026 Mon, 17 Aug 2026

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

IMDEX Limited (ASX:IMD) delivered a standout FY26 with 21% revenue growth to $520 million and a 44% jump in net profit to $79 million, driven by organic growth and five key acquisitions. The company raised its dividend and expanded its digital earth science footprint, positioning for further gains.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Diablo Resources has secured an 80% stake in the historic Horn Silver Project in Utah, unlocking a portfolio of high-grade silver, gold, copper, and antimony targets. The acquisition complements its nearby Star Range assets and aligns with US critical minerals priorities.

Macmahon Holdings has agreed to sell a partial stake in its Homeground accommodation village to Allcap Securities, aligning itself with a $20 billion infrastructure push in Gladstone. The deal opens doors for Macmahon to tap into civil contracting opportunities linked to the massive Project Velocity.

BlueScope Steel posted a remarkable 857% jump in reported NPAT to $802 million for FY2026, underpinned by strong US spreads, cost discipline, and growth in value-added steel products. The company declared record dividends and advanced key decarbonisation projects, signaling a confident transition from investment to shareholder returns.

Marlin Global delivered a robust 3.1% gross portfolio return in July 2026, significantly outpacing its benchmark which fell 3.6%, thanks to strategic semiconductor underweighting and strong gains in tech giants Microsoft, Dexcom, and Amazon.

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

Freightways reported a solid FY26 with 13.5% revenue growth to NZD 1.46 billion and a 17.3% rise in net profit, underpinned by strong Australian market gains and operational efficiencies despite economic headwinds.

Mangawhai Collective aims to boost its stake in Bremworth from 19.73% to a controlling interest by offering NZD 0.90 per share for nearly 44% of outstanding shares, subject to conditions and shareholder precommitments.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.